Assignment: NUR 506 Module 1 Begin Preparing for Agency Synopsis Paper
Assignment: NUR 506 Module 1 Begin Preparing for Agency Synopsis Paper
Agency Synopsis
Identify regulatory agencies that regulate health and the health care system within the US, create a table listing your 5 regulatory agencies and address the following:
Describe the agency, level of regulatory authority (local, state, federal), scope of regulatory authority, and role within the US healthcare system.
ORDER A CUSTOMIZED, PLAGIARISM-FREE PAPER HERE
Good News For Our New customers . We can help you in Completing this assignment and pay after Delivery. Our Top -rated medical writers will comprehensively review instructions , synthesis external evidence sources(Scholarly) and customize a quality assignment for you. We will also attach a copy of plagiarism report alongside, AI report alongside the assignment. Feel free to chat Us
Address relevance of the organization or the organization’s authority to the APRN/DNP graduate.
Describe relevance to specialty area, area of practice, or setting of practice. For an example, mental health.
Submission Requirements:
In the table, write the 3 criteria above and respond to them.
The table is to be clear and concise and students will lose points for improper grammar, punctuation and misspelling.
The table is to be complete and thorough. It should include all items indicated in the assignment.
Incorporate at least 3 current (published within last five years) scholarly journal articles or primary legal sources (statutes, court opinions) within your work.
ORDER A CUSTOMIZED, PLAGIARISM-FREE PAPER HERE
Begin Preparing for Agency Synopsis Paper
Regulation plays a vital role in the healthcare and insurance sectors, safeguarding consumers from health hazards, establishing a secure workplace for healthcare professionals, and promoting public health and welfare through various health programs. The system operates effectively across various levels, adhering to regulatory standards established by both governmental and private entities. Regulations play a crucial role in the healthcare industry by establishing uniform standards and providing oversight to ensure adherence to public health policies and the delivery of safe care to patients and visitors (Saldanha et al., 2022). Monitoring practitioners and facilities, reporting industry changes to the government, adherence to safety standards, and compliance with local, state, and federal guidelines all contribute to enhancing healthcare quality. This paper provides a descriptive analysis of the regulatory agencies responsible for overseeing the healthcare system in the United States.
Regulatory Agencies in the United States
Agency description, level of regulatory authority, and scope of regulatory authority. Relevance of the organization to APRN/DNP graduates Relevance to specialty area, area of practice, or setting of practice
1. The Centres for Disease Control and Prevention (CDC) The CDC is the primary federal organization dedicated to safeguarding the well-being and welfare of the entire nation. The organization is responsible for establishing the foundation for implementing, formulating, and preventing diseases, safeguarding the environment, and promoting knowledge about health and educational initiatives that contribute to enhancing health (Celtik et al., 2022). The CDC is a constantly accessible agency that operates around the clock to safeguard the American population from disease threats and outbreaks. The primary focus is identifying and controlling disease outbreaks from their source, which is crucial due to its efficiency and cost-effectiveness in minimizing healthcare expenses. In addition, the organization works with other entities to conduct extensive research to safeguard the nation from possible health threats. In addition, it has collaborated with other health societies to establish performance standards required for the award of accreditation of governmental public health action (Celtik et al., 2022). The CDC aims to safeguard individuals and preserve lives by mitigating health hazards. The platform shares healthcare data to safeguard the United States from expensive and hazardous healthcare issues and promptly address them if they arise. In order to accomplish this, the researchers conducted the required investigation (Celtik et al., 2022).
2. Food and Drug Administration (FDA) The FDA is a federal agency responsible for safeguarding food safety for consumers in the United States. Furthermore, it is responsible for regulating and supervising various sectors, including human pharmaceuticals, veterinary medicine, medical devices, cosmetics, biological products, radiation substances, and healthcare electronics (Zhang et al., 2020). The agency is crucial in providing up-to-date information to APRNs and DNP graduates regarding the latest research and concerns related to pharmaceutical products and food safety. This ensures that patients receive safe and effective treatment for their health. The FDA provides valuable insights into how nurses can streamline the process of selecting the drug that works best or food for patients. By implementing the findings of this research, nurses can alleviate their burden and enhance patient care (Zhang et al., 2020). The FDA guarantees the safety of individuals and the healthcare system. The FDA ensures that medications are safe and that medical devices are a big part of trying to lessen possible user injury. The FDA monitors the consumption of food, tobacco, and medications totaling more than $2.7 trillion. This indicates that it has been assigned the most important duty to complete successfully (Zhang et al., 2020).
3. Centres for Medicare and Medicaid Services (CMS) The federal agency managing the nation’s basic healthcare programs, including Medicaid and Medicare, is called the CMS. The organization gathers and examines information, generates studies, looks into allegations of fraud and abuse, and removes them from the healthcare system. This enhances the quality of care. Additionally, the CMS modifies the Medicare premium data (Wadhera et al., 2020). The CMS can issue directives and regulations to enhance access to appropriate treatment for Medicaid and Medicare beneficiaries. CMS ensures that its guidelines and policies are updated to align with the evolving practice capabilities of licensed healthcare providers. This ensures that the information remains relevant and up-to-date, considering the changing landscape of healthcare providers. The CMS introduced a concept that proved advantageous for medical professionals by allowing them to expand their expertise (Wadhera et al., 2020). The CMS is responsible for failing to notice the nation’s preliminary healthcare plans, including Medicaid, Medicare, and CHIP. The CMS gathers and evaluates data that is critical for enhancing the delivery of care and the availability of coverage. Furthermore, it is pertinent because it consistently furnishes updates concerning revised Medicare premiums (Wadhera et al., 2020).
4. Agency for Healthcare Research and Quality (AHRQ) The AHRQ is a federal agency charged with enhancing the country’s safety and quality of healthcare. It furnishes trustworthy information and generates indispensable data and tools, both critical for enhancing healthcare delivery and assisting practitioners in making informed decisions (Brach & Borsky, 2020). AHRQ’s mission is to provide the necessary evidence to enhance the safety, accessibility, equity, and quality of the healthcare system. The objective is to present compelling evidence that enhances the safety, accessibility, integrity, and quality of healthcare in the United States. It works with various institutions, including the US Department of Health and Human Services, to guarantee that its data is clearly, easily understandable, and utilized appropriately. In addition, the organization has implemented a policy to address and prevent discrimination. The statement endorses initiatives to achieve fairness and equality, irrespective of factors such as color, race, and gender (Brach & Borsky, 2020). AHRQ primarily directs its efforts towards funding research in the healthcare field, specifically focusing on improving the national healthcare delivery system. This includes providing education and support to primary care clinicians, particularly in rural areas, to enhance their ability to deliver comprehensive care to patients and providing clinicians with the necessary tools to screen and manage a range of healthcare conditions, including mental health, substance abuse, and HIV. AHRQ’s primary focus is developing data and legislation for policymakers. Medicare and CHIP utilize the provided figures to evaluate their program’s eligibility (Brach & Borsky, 2020).
5. National Institute of Health NIH The NIH is a prominent government institution that conducts and preserves medical research. The NIH aims to acquire essential knowledge regarding the nature and functioning of biological systems and to utilize this information to enhance healthcare and reduce the prevalence of diseases such as cancer (Prasad et al., 2020). The NIH plays a crucial role in enhancing healthcare by promoting effective management, facilitating economic growth, and increasing productivity in the field of health. These efforts aim to prevent health issues and contribute to the community. Furthermore, it aids in the progression of biomedical knowledge by providing financial support for state-of-the-art research (Prasad et al., 2020). The National Institutes of Health conducts extensive medical research on chronic illnesses to establish the scientific basis for clinical practices, medication, symptom management, and disease prevention across various conditions. Additionally, it aims to enhance palliative and end-of-life care (Prasad et al., 2020).
References
Brach, C., & Borsky, A. (2020). How the U.S. Agency for Healthcare Research and Quality Promotes Health Literate Health Care. Studies in Health Technology and Informatics, 269, 313–323. https://doi.org/10.3233/shti200046
Celtik, K., Wallis, C., Lo, M., Lim, K., Lipscomb, J., Fleming, S., Wu, X., Anderson, R., Thompson, T., Farach, A., Hamilton, A., Miles, B., & Satkunasivam, R. (2022). Localized prostate cancer: An analysis of the CDC Breast and Prostate Cancer Data Quality and Patterns of Care study (CDC PoC-BP). Canadian Urological Association Journal, 16(7). https://doi.org/10.5489/cuaj.7580
Prasad, J. M., Shipley, M. T., Rogers, T. B., & Puche, A. C. (2020). National Institutes of Health (NIH) grant awards: Does past performance predict future success? Palgrave Communications, 6(1). https://doi.org/10.1057/s41599-020-0432-5
Saldanha, I. J., Dodd, S., Fish, R., Gorst, S. L., Hall, D. A., Jacobsen, P., Kirkham, J. J., Trepel, D., & Williamson, P. R. (2022). Comparison of published core outcome sets with outcomes recommended in regulatory guidance from the US Food and Drug Administration and European Medicines Agency: cross-sectional analysis. BMJ Medicine, 1(1), e000233. https://doi.org/10.1136/bmjmed-2022-000233
Wadhera, R. K., Figueroa, J. F., Maddox, K. E. J., Rosenbaum, L. S., Kazi, D. S., & Yeh, R. W. (2020). Quality Measure Development and Associated Spending by the Centers for Medicare & Medicaid Services. JAMA, 323(16), 1614. https://doi.org/10.1001/jama.2020.1816
Zhang, A. D., Puthumana, J., Downing, N. S., Shah, N. D., Krumholz, H. M., & Ross, J. S. (2020). Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017. JAMA Network Open, 3(4), e203284. https://doi.org/10.1001/jamanetworkopen.2020.3284
